|
Control
|
DKA
|
NKH
|
---|
Before treatment
|
After treatment
|
Before treatment
|
After treatment
|
---|
Blood glucose (mmol/L)
|
5.18 ± 2.76
|
23.09 ± 9.43a
|
7.26 ± 4.60b
|
25.86 ± 11.66a
|
7.95 ± 4.38b
|
HbA1c (%)
|
5.60 ± 1.28
|
13.87 ± 9.51a
| |
14.78 ± 6.28a
| |
APH
|
7.39 ± 2.11
|
7.19 ± 4.78a
|
7.37 ± 3.15b
|
7.38 ± 3.01
|
7.39 ± 4.64
|
HCO3−(mmol/L)
|
24.12 ± 2.20
|
12.35 ± 1.98a
|
23.85 ± 2.67b
|
23.43 ± 2.62
|
23.55 ± 3.25
|
Ketones in urine
|
−
|
+
|
−
|
−
|
−
|
Effective osmolality (mmol/L)
|
284.20 ± 14.71
|
280.43 ± 16.04
|
282.76 ± 14.39
|
290.62 ± 18.71
|
291.53 ± 20.35
|
Anion gaps (mmol/L)
|
12.11 ± 3.10
|
29.15 ± 5.88a
|
13.56 ± 4.04b
|
12.87 ± 4.80
|
11.38 ± 5.18
|
C-peptide (nmol/L)
|
0.76 ± 0.07
|
0.34 ± 0.05a
|
0.35 ± 0.09a
|
0.41 ± 0.09a
|
0.43 ± 0.09a
|
- DKA: diabetic ketoacidosis group; NKH: non-ketotic hyperglycemia group; control group: healthy individuals
- aP < 0.05, compared with controls
- bP < 0.05, compared with the same group before treatment